[Hiring] Accounting Manager @Elicio Therapeutics

Role Description

Accounting Manager (Contractor – 6 Months to cover an LOA)

Reporting to the Assistant Controller, this individual will serve as an integral team member with exposure to multiple facets of business operations. The Accounting Manager will be responsible for leading or supporting many of Elicio’s accounting activities, including:

• General ledger
• Monthly/quarterly close process
• Payroll
• Treasury
• Internal controls
• Financial reporting

The Accounting Manager will work closely with the various members of the Company.

Major Duties/Responsibilities:

• Lead day-to-day close and accrual processes including preparing/reviewing journal entries.
• Own preparation of monthly R&D accruals including collaborating with department leaders and outside contract research organizations.
• Prepare quarterly stock compensation calculations.
• Prepare warrant liability calculations.
• Manage leases including maintaining the reconciliations and booking the monthly journal entries.
• Prepare internal reporting package.
• Oversee senior accountant including supervision of tasks and review of reconciliations/journal entries.
• Ownership of AP & payroll.
• Promote a culture of collaboration, cooperation, cross-functional inclusion, execution excellence, effective communication and cross-functional problem-solving to become a high-performing team.
• Other AD HOC projects.

Qualifications

• Degree in Business, Accounting or Finance, Master's degree preferred.
• 5+ years of relevant accounting experience in biotech or life sciences industry. Prior public accounting experience preferred.

Requirements

• NetSuite experience preferred.
• Strong working knowledge in general ledger, GAAP, AP, payroll, and accruals.
• Proficiency in Microsoft Office applications required, including Excel and Word.
• Excellent communication skills, with the ability to collaborate effectively with cross-functional teams.
• Strong team player with the ability to work in a fast-paced environment, manage competing priorities, while filling gaps as needed.

Company Description

Elicio Therapeutics, Inc. (Nasdaq: ELTX) is a clinical-stage biotechnology company advancing a pipeline of novel lymph node-targeted immunotherapies for the treatment of some of the most aggressive cancers. By combining expertise in immunology and immunotherapy, Elicio is harnessing the natural power of the immune system with the AMP technology, which allows for therapeutic payloads to be delivered directly to the lymph nodes, with the goal of enhancing the immune system’s cancer-fighting capabilities.

For more information, please visit www.elicio.com .